Webinar on Ketamine and Next Generation Therapies Featuring NIMH’s Carlos A. Zarate, M.D.
Science Update •
On August 13, 2013, Carlos A. Zarate, M.D., from the National Institute of Mental Health will give a live presentation titled “Ketamine & Next Generation Therapies,” where he will discuss his research on novel medications for treatment-resistant depression and bipolar disorder at the Brain and Behavior Research Foundation.
Register for this webinar to learn more about Dr. Zarate’s work on novel treatments for depression and bipolar disorder, including ketamine and other experimental fast-acting antidepressant medications. Join either by phone or on the web from 2 to 3 p.m. EST. A discussion and Q&A session will follow the presentation.